Fructosyl-lysine dihydrochloride serves as a precursor to glucosepane, a lysine-arginine protein crosslink used as a biomarker for diabetes; it is utilized in studies investigating advanced glycation end-products (AGEs) in diabetic complications; it supports bacterial growth as a carbon source in E. coli; and it is involved in the enzymatic phosphorylation pathway leading to glucose 6-phosphate formation in bacterial extracts.